查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1729294

日本基因治疗市场报告（按基因类型、载体类型、递送方式、应用和地区）2025-2033

Japan Gene Therapy Market Report by Gene Type, Vector Type, Delivery Method, Application, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 119 Pages | 商品交期: 5-7个工作天内

价格
简介目录

2024年日本基因治疗规模达3.43亿美元。展望未来， IMARC Group预计到2033年市场规模将达到11.332亿美元，2025-2033年期间的成长率（CAGR）为14.2%。遗传疾病的盛行率不断上升、基因编辑技术的最新进展、日本政府实施的支持政策以及对研发 (R&D) 的不断增加的投资是推动市场发展的一些关键因素。

基因治疗是医学领域的突破性方法，旨在透过修改个别细胞内的基因来治疗并可能根除疾病。这项先进的技术包括在患者细胞中引入、删除或改变遗传物质，主要目的是纠正导致各种疾病的基因异常。基因治疗的基本组成部分包括治疗性脱氧核糖核酸（DNA）、促进 DNA 转移到细胞中的传递载体以及复杂的基因编辑技术，例如 CRISPR。它可应用于众多领域，包括癌症治疗、病毒感染管理、心血管疾病（CVD）、神经系统疾病、自体免疫疾病、与年龄相关的疾病、特定类型的失明以及遗传性疾病，包括血友病、囊性纤维化和镰状细胞疾病。

日本基因治疗市场趋势：

日本遗传疾病和癌症的发生率不断上升，促使人们需要基因治疗等创新治疗方法，以推动市场成长。此外，CRISPR/Cas9 等基因编辑技术的最新进展提高了基因改造的准确性并提高了治疗的成功率，促进了市场的成长。此外，製药和生物技术公司在研发（R&D）活动方面投入了大量资金，以开发有效和创新的基因疗法，从而推动了市场的成长。同时，日本政府实施的支持性法规和政策，加快审批流程并促进基因治疗试验和产品的发展，正在刺激市场成长。除此之外，先进的载体传递系统的出现，提高了基因治疗的疗效，最大限度地减少了潜在的副作用，从而确保了更有效、更安全的治疗选择，支持了市场的成长。此外，医疗保健专业人员和患者对基因疗法及其潜在益处的认识不断提高，这也促进了市场的成长。除此之外，大学、研究机构和公司之间日益增长的策略联盟和合作，旨在促进创新和拓宽商业化潜力，从而催化市场成长。此外，老年人口不断增加，极易患上各种与年龄相关的疾病，如帕金森氏症、骨关节炎、阿兹海默症和老年黄斑部病变（AMD），这也推动了市场的成长。预计其他因素也将推动市场成长，包括医疗保健支出的增加、精准医疗的日益普及以及对创新疗法的需求的增加。

日本基因治疗市场细分：

基因类型洞察：

  • 抗原
  • 细胞因子
  • 肿瘤抑制因子
  • 自杀基因
  • 不足
  • 生长因子
  • 受体
  • 其他的

向量类型洞察：

  • 病毒载体
    • 腺病毒
    • 慢病毒
    • 逆转录病毒
    • 腺相关病毒
    • 单纯疱疹病毒
    • 痘病毒
    • 痘苗病毒
    • 其他的
  • 非病毒技术
    • 裸载体和质粒载体
    • 基因枪
    • 电穿孔
    • 脂质体转染
    • 其他的

交付方式洞察：

  • 体内基因治疗
  • 体外基因治疗

应用程式洞察：

  • 肿瘤疾病
  • 罕见疾病
  • 心血管疾病
  • 神经系统疾病
  • 传染病
  • 其他的

本报告回答的关键问题：

  • 日本基因治疗市场迄今表现如何？未来几年将如何表现？
  • COVID-19 对日本基因治疗市场有何影响？
  • 根据基因类型，日本基因治疗市场是如何分類的？
  • 根据载体类型，日本基因治疗市场是如何分類的？
  • 根据交付方式，日本基因治疗市场是如何分類的？
  • 日本基因治疗市场根据应用如何划分？
  • 日本基因治疗市场的价值链分为哪些阶段？
  • 日本基因治疗市场的主要驱动因素和挑战是什么？
  • 日本基因治疗市场的结构是怎么样的？主要参与者是谁？
  • 日本基因治疗市场的竞争程度如何？

本报告回答的关键问题：

  • 日本基因治疗市场迄今表现如何？未来几年将如何表现？
  • COVID-19 对日本基因治疗市场有何影响？
  • 根据基因类型，日本基因治疗市场是如何分類的？
  • 根据载体类型，日本基因治疗市场是如何分類的？
  • 根据交付方式，日本基因治疗市场是如何分類的？
  • 日本基因治疗市场根据应用如何划分？
  • 日本基因治疗市场的价值链分为哪些阶段？
  • 日本基因治疗市场的主要驱动因素和挑战是什么？
  • 日本基因治疗市场的结构是怎么样的？主要参与者是谁？
  • 日本基因治疗市场的竞争程度如何？

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：日本基因治疗市场-简介

  • 概述
  • 市场动态
  • 产业趋势
  • 竞争情报

第五章：日本基因治疗市场格局

  • 历史与当前市场趋势（2019-2024）
  • 市场预测（2025-2033）

第六章：日本基因治疗市场-细分：依基因类型

  • 抗原
    • 概述
  • 细胞因子
    • 概述
  • 肿瘤抑制因子
    • 概述
  • 自杀基因
    • 概述
  • 不足
    • 概述
  • 生长因子
    • 概述
  • 受体
    • 概述
  • 其他的
    • 概述

第七章：日本基因治疗市场-细分：依载体类型

  • 病毒载体
    • 概述
    • 市场区隔
      • 腺病毒
      • 慢病毒
      • 逆转录病毒
      • 腺相关病毒
      • 单纯疱疹病毒
      • 痘病毒
      • 痘苗病毒
      • 其他的
  • 非病毒技术
    • 概述
    • 市场区隔
      • 裸载体和质粒载体
      • 基因枪
      • 电穿孔
      • 脂质体转染
      • 其他的

第 8 章：日本基因治疗市场 - 细分：以交付方式

  • 体内基因治疗
    • 概述
  • 体外基因治疗
    • 概述

第九章：日本基因治疗市场-细分：依应用

  • 肿瘤疾病
    • 概述
  • 罕见疾病
    • 概述
  • 心血管疾病
    • 概述
  • 神经系统疾病
    • 概述
  • 传染病
    • 概述
  • 其他的
    • 概述

第十章：日本基因治疗市场-竞争格局

  • 概述
  • 市场结构
  • 市场参与者定位
  • 最佳获胜策略
  • 竞争仪錶板
  • 公司评估象限

第 11 章：关键参与者简介

  • Company A
    • Business Overview
    • Services Offered
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company B
    • Business Overview
    • Services Offered
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company C
    • Business Overview
    • Services Offered
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company D
    • Business Overview
    • Services Offered
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company E
    • Business Overview
    • Services Offered
    • Business Strategies
    • SWOT Analysis
    • Major News and Events

第 12 章：日本基因治疗市场 - 产业分析

  • 驱动因素、限制因素和机会
    • 概述
    • 驱动程式
    • 限制
    • 机会
  • 波特五力分析
    • 概述
    • 买家的议价能力
    • 供应商的议价能力
    • 竞争程度
    • 新进入者的威胁
    • 替代品的威胁
  • 价值链分析

第 13 章：附录

简介目录
Product Code: SR112025A9327

The Japan gene therapy size reached USD 343.0 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,133.2 Million by 2033, exhibiting a growth rate (CAGR) of 14.2% during 2025-2033. The escalating prevalence of genetic disorders, recent advancements in gene editing technologies, implementation of supportive policies by the Government of Japan, and the increasing investment in research and development (R&D) represent some of the key factors driving the market.

Gene therapy is a groundbreaking approach in the medical field, designed to address and potentially eradicate diseases through the modification of genes within an individual's cells. This advanced technique encompasses the introduction, deletion, or alteration of genetic material in a patient's cells, with the primary aim of rectifying the genetic anomalies causing various diseases. The essential components of gene therapy include therapeutic deoxyribonucleic acid (DNA), a delivery vector that facilitates the transfer of DNA into cells, and sophisticated gene-editing technologies, such as CRISPR. It finds application across numerous domains, including cancer treatment, management of viral infections, tackling cardiovascular diseases (CVDs), neurological disorders, autoimmune diseases, age-related illnesses, specific types of blindness, and genetic disorders, including hemophilia, cystic fibrosis, and sickle cell disease.

Japan Gene Therapy Market Trends:

The escalating prevalence of genetic disorders and cancers in Japan, which has prompted the need for innovative treatment methods, such as gene therapy, is propelling the market growth. Additionally, the recent advancements in gene editing technologies such as CRISPR/Cas9, which have improved the accuracy of gene modifications and enhanced the success rates of therapies, are contributing to the market growth. Furthermore, the substantial investments in research and development (R&D) activities by pharmaceutical and biotech companies to develop effective and innovative gene therapies are boosting the market growth. Along with this, the implementation of supportive regulations and policies by the Government of Japan to accelerate approval processes and promote gene therapy trials and products is stimulating the market growth. Besides this, the emergence of advanced vector delivery systems, which improve gene therapy's efficacy and minimize potential side effects, thus ensuring more effective and safer treatment options, is supporting the market growth. Moreover, the heightened awareness about gene therapy and its potential benefits among healthcare professionals and patients is strengthening the market growth. Apart from this, the growing strategic alliances and collaborations among universities, research institutions, and companies to boost innovation and broaden the potential for commercialization are catalyzing the market growth. In addition, the escalating geriatric population, which is highly susceptible to various age-related diseases, such as Parkinson's disease, osteoarthritis, Alzheimer's disease, and age-related macular degeneration (AMD), is fueling the market growth. Other factors, including rising healthcare expenditure, growing adoption of precision medicines, and increasing demand for innovative therapies, are anticipated to drive the market growth.

Japan Gene Therapy Market Segmentation:

Gene Type Insights:

  • Antigen
  • Cytokine
  • Tumor Suppressor
  • Suicide Gene
  • Deficiency
  • Growth Factors
  • Receptors
  • Others

Vector Type Insights:

  • Viral Vector
    • Adenoviruses
    • Lentiviruses
    • Retroviruses
    • Adeno-Associated Virus
    • Herpes Simplex Virus
    • Poxvirus
    • Vaccinia Virus
    • Others
  • Non-Viral Techniques
    • Naked and Plasmid Vectors
    • Gene Gun
    • Electroporation
    • Lipofection
    • Others

Delivery Method Insights:

  • In-Vivo Gene Therapy
  • Ex-Vivo Gene Therapy

Application Insights:

  • Oncological Disorders
  • Rare diseases
  • Cardiovascular Diseases
  • Neurological Disorders
  • Infectious Disease
  • Others

Competitive Landscape:

  • The report has also provided a comprehensive analysis of the competitive landscape in the Japan gene therapy market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

  • How has the Japan gene therapy market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan gene therapy market?
  • What is the breakup of the Japan gene therapy market on the basis of gene type?
  • What is the breakup of the Japan gene therapy market on the basis of vector type?
  • What is the breakup of the Japan gene therapy market on the basis of delivery method?
  • What is the breakup of the Japan gene therapy market on the basis of application?
  • What are the various stages in the value chain of the Japan gene therapy market?
  • What are the key driving factors and challenges in the Japan gene therapy market?
  • What is the structure of the Japan gene therapy market and who are the key players?
  • What is the degree of competition in the Japan gene therapy market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Gene Therapy Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Gene Therapy Market Landscape

  • 5.1 Historical and Current Market Trends (2019-2024)
  • 5.2 Market Forecast (2025-2033)

6 Japan Gene Therapy Market - Breakup by Gene Type

  • 6.1 Antigen
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2019-2024)
    • 6.1.3 Market Forecast (2025-2033)
  • 6.2 Cytokine
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2019-2024)
    • 6.2.3 Market Forecast (2025-2033)
  • 6.3 Tumor Suppressor
    • 6.3.1 Overview
    • 6.3.2 Historical and Current Market Trends (2019-2024)
    • 6.3.3 Market Forecast (2025-2033)
  • 6.4 Suicide Gene
    • 6.4.1 Overview
    • 6.4.2 Historical and Current Market Trends (2019-2024)
    • 6.4.3 Market Forecast (2025-2033)
  • 6.5 Deficiency
    • 6.5.1 Overview
    • 6.5.2 Historical and Current Market Trends (2019-2024)
    • 6.5.3 Market Forecast (2025-2033)
  • 6.6 Growth Factors
    • 6.6.1 Overview
    • 6.6.2 Historical and Current Market Trends (2019-2024)
    • 6.6.3 Market Forecast (2025-2033)
  • 6.7 Receptors
    • 6.7.1 Overview
    • 6.7.2 Historical and Current Market Trends (2019-2024)
    • 6.7.3 Market Forecast (2025-2033)
  • 6.8 Others
    • 6.8.1 Overview
    • 6.8.2 Historical and Current Market Trends (2019-2024)
    • 6.8.3 Market Forecast (2025-2033)

7 Japan Gene Therapy Market - Breakup by Vector Type

  • 7.1 Viral Vector
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2019-2024)
    • 7.1.3 Market Segmentation
      • 7.1.3.1 Adenoviruses
      • 7.1.3.2 Lentiviruses
      • 7.1.3.3 Retroviruses
      • 7.1.3.4 Adeno-Associated Virus
      • 7.1.3.5 Herpes Simplex Virus
      • 7.1.3.6 Poxvirus
      • 7.1.3.7 Vaccinia Virus
      • 7.1.3.8 Others
    • 7.1.4 Market Forecast (2025-2033)
  • 7.2 Non-Viral Techniques
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2019-2024)
    • 7.2.3 Market Segmentation
      • 7.2.3.1 Naked and Plasmid Vectors
      • 7.2.3.2 Gene Gun
      • 7.2.3.3 Electroporation
      • 7.2.3.4 Lipofection
      • 7.2.3.5 Others
    • 7.2.4 Market Forecast (2025-2033)

8 Japan Gene Therapy Market - Breakup by Delivery Method

  • 8.1 In-Vivo Gene Therapy
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2019-2024)
    • 8.1.3 Market Forecast (2025-2033)
  • 8.2 Ex-Vivo Gene Therapy
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2019-2024)
    • 8.2.3 Market Forecast (2025-2033)

9 Japan Gene Therapy Market - Breakup by Application

  • 9.1 Oncological Disorders
    • 9.1.1 Overview
    • 9.1.2 Historical and Current Market Trends (2019-2024)
    • 9.1.3 Market Forecast (2025-2033)
  • 9.2 Rare Diseases
    • 9.2.1 Overview
    • 9.2.2 Historical and Current Market Trends (2019-2024)
    • 9.2.3 Market Forecast (2025-2033)
  • 9.3 Cardiovascular Diseases
    • 9.3.1 Overview
    • 9.3.2 Historical and Current Market Trends (2019-2024)
    • 9.3.3 Market Forecast (2025-2033)
  • 9.4 Neurological Disorders
    • 9.4.1 Overview
    • 9.4.2 Historical and Current Market Trends (2019-2024)
    • 9.4.3 Market Forecast (2025-2033)
  • 9.5 Infectious Disease
    • 9.5.1 Overview
    • 9.5.2 Historical and Current Market Trends (2019-2024)
    • 9.5.3 Market Forecast (2025-2033)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Historical and Current Market Trends (2019-2024)
    • 9.6.3 Market Forecast (2025-2033)

10 Japan Gene Therapy Market - Competitive Landscape

  • 10.1 Overview
  • 10.2 Market Structure
  • 10.3 Market Player Positioning
  • 10.4 Top Winning Strategies
  • 10.5 Competitive Dashboard
  • 10.6 Company Evaluation Quadrant

11 Profiles of Key Players

  • 11.1 Company A
    • 11.1.1 Business Overview
    • 11.1.2 Services Offered
    • 11.1.3 Business Strategies
    • 11.1.4 SWOT Analysis
    • 11.1.5 Major News and Events
  • 11.2 Company B
    • 11.2.1 Business Overview
    • 11.2.2 Services Offered
    • 11.2.3 Business Strategies
    • 11.2.4 SWOT Analysis
    • 11.2.5 Major News and Events
  • 11.3 Company C
    • 11.3.1 Business Overview
    • 11.3.2 Services Offered
    • 11.3.3 Business Strategies
    • 11.3.4 SWOT Analysis
    • 11.3.5 Major News and Events
  • 11.4 Company D
    • 11.4.1 Business Overview
    • 11.4.2 Services Offered
    • 11.4.3 Business Strategies
    • 11.4.4 SWOT Analysis
    • 11.4.5 Major News and Events
  • 11.5 Company E
    • 11.5.1 Business Overview
    • 11.5.2 Services Offered
    • 11.5.3 Business Strategies
    • 11.5.4 SWOT Analysis
    • 11.5.5 Major News and Events

12 Japan Gene Therapy Market - Industry Analysis

  • 12.1 Drivers, Restraints and Opportunities
    • 12.1.1 Overview
    • 12.1.2 Drivers
    • 12.1.3 Restraints
    • 12.1.4 Opportunities
  • 12.2 Porters Five Forces Analysis
    • 12.2.1 Overview
    • 12.2.2 Bargaining Power of Buyers
    • 12.2.3 Bargaining Power of Suppliers
    • 12.2.4 Degree of Competition
    • 12.2.5 Threat of New Entrants
    • 12.2.6 Threat of Substitutes
  • 12.3 Value Chain Analysis

13 Appendix